FDA Inspection 1303694 — Charles River Laboratories, Inc.

Charles River Laboratories, Inc. — FEI 1000121235

The FDA completed an inspection of Charles River Laboratories, Inc. on January 20, 2026 in Malvern, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 20, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Malvern, PA (United States)